title: oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.
abstract: CD36, belongs to class B scavenger receptor family, is a macrophage receptor for oxidized low-density lipoprotein (oxLDL) and has been proven to play a critical role in atherosclerotic foam cell formation. In addition, CD36 expression is regulated by many factors including oxLDL and HDL. A recent study suggests that CD36 can also bind with oxidized high-density lipoprotein (oxHDL). However, the direct role of oxHDL in atherosclerosis is still not clear and it is not known whether oxHDL has any influence on the expression of CD36 in macrophages. Here, we performed experiments to investigate the effect of oxHDL on the expression of CD36 on human peripheral blood monocytes-macrophages and the possible mechanisms. Our results suggest that the uptake of oxHDL by CD36 on macrophages accelerates foam cell formation. In addition, oxHDL can down-regulate both the mRNA and surface protein expression of CD36 on human peripheral macrophages in vitro. oxHDL increased the mRNA expression and protein phosphorylation of peroxisome proliferators-activated receptor-gamma (PPARgamma). Using different mitogen-activated protein kinase (MAPK) inhibitors, we demonstrated that oxHDL regulated CD36 and PPARgamma expression in a p38-MAP kinase dependent mechanism.
authors.affiliation: Department of cardiology, Peking University People's Hospital, Beijing, China.
authors.forename: Jingyi
authors.initials: J
authors.lastname: Ren
authors.forename: Wenying
authors.initials: W
authors.lastname: Jin
authors.forename: Hong
authors.initials: H
authors.lastname: Chen
mesh_terms: D015153:Blotting, Western; D018955:CD36 Antigens / Q000378:metabolism*; D002478:Cells, Cultured; D005434:Flow Cytometry; D005487:Foam Cells / Q000378:metabolism; D006801:Humans; D008075:Lipoproteins, HDL / Q000737:chemistry* / Q000378:metabolism*; D008264:Macrophages / Q000166:cytology / Q000378:metabolism*; D009000:Monocytes / Q000166:cytology / Q000378:metabolism; D047495:PPAR gamma / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D048051:p38 Mitogen-Activated Protein Kinases / Q000378:metabolism*
chemical_list: D018955:CD36 Antigens; D008075:Lipoproteins, HDL; D047495:PPAR gamma; D012333:RNA, Messenger; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: Free Radic Biol Med. 2006 May 15;40(10):1796-803
references.pmid: 16678017
references.citation: Nat Med. 2001 Jan;7(1):41-7
references.pmid: 11135614
references.citation: J Biol Chem. 1999 Jan 1;274(1):41-7
references.pmid: 9867808
references.citation: J Clin Invest. 1995 Oct;96(4):1859-65
references.pmid: 7560077
references.citation: Curr Opin Genet Dev. 1995 Oct;5(5):571-6
references.pmid: 8664544
references.citation: J Biol Chem. 2002 Jun 28;277(26):23582-6
references.pmid: 11953427
references.citation: J Clin Invest. 2005 Aug;115(8):2192-201
references.pmid: 16075060
references.citation: J Biol Chem. 2002 Dec 20;277(51):49982-8
references.pmid: 12376530
references.citation: Curr Opin Cardiol. 2008 Jul;23(4):370-8
references.pmid: 18520722
references.citation: J Clin Invest. 2000 Apr;105(8):1049-56
references.pmid: 10772649
references.citation: J Biol Chem. 1999 Jul 2;274(27):19055-62
references.pmid: 10383407
references.citation: Atherosclerosis. 2006 Jan;184(1):1-7
references.pmid: 16157342
references.citation: Biochim Biophys Acta. 2000 Jan 17;1483(2):217-35
references.pmid: 10634938
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: FASEB J. 2001 Apr;15(6):1095-7
references.pmid: 11292679
references.citation: Proc Natl Acad Sci U S A. 2004 Aug 31;101(35):13032-7
references.pmid: 15326314
references.citation: Circulation. 2004 Feb 17;109(6):790-6
references.pmid: 14970117
references.citation: J Lipid Res. 2000 May;41(5):688-96
references.pmid: 10787429
references.citation: Ann Clin Biochem. 2000 Mar;37 ( Pt 2):179-86
references.pmid: 10735361
references.citation: FEBS Lett. 2007 Mar 20;581(6):1227-32
references.pmid: 17346709
references.citation: Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1583-8
references.pmid: 12855483
references.citation: Br J Haematol. 2004 Oct;127(1):97-104
references.pmid: 15384983
references.citation: Int J Biochem Cell Biol. 2007;39(11):2012-30
references.pmid: 17466567
references.citation: J Mol Biol. 2008 Feb 29;376(4):997-1007
references.pmid: 18190928
references.citation: Biochem Pharmacol. 2004 Jan 15;67(2):303-13
references.pmid: 14698043
references.citation: Circ Res. 2004 Oct 29;95(9):858-66
references.pmid: 15514167
references.citation: Cardiovasc Res. 2007 Aug 1;75(3):468-77
references.pmid: 17442283
references.citation: Cardiovasc Res. 2007 Aug 1;75(3):566-74
references.pmid: 17524375
references.citation: Vascul Pharmacol. 2004 May-Jun;41(4-5):139-46
references.pmid: 15607497